e-learning
resources
Stockholm 2007
Monday 17.09.2007
Treatment options in obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of nasal topical steroids on CPAP compliance in patients with obstructive sleep apnoea starting therapy
W. Strobel, D. Miedinger, J. Leuppi, M. Tamm (Basel, Switzerland)
Source:
Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Session:
Treatment options in obstructive sleep apnoea
Session type:
Electronic Poster Discussion
Number:
2769
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. Strobel, D. Miedinger, J. Leuppi, M. Tamm (Basel, Switzerland). Effect of nasal topical steroids on CPAP compliance in patients with obstructive sleep apnoea starting therapy. Eur Respir J 2007; 30: Suppl. 51, 2769
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Clinical case discussion: ERS guidelines on high flow nasal cannula in acute respiratory failure: from the clinical cases to the scientific evidence
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
Related content which might interest you:
Objective compliance with oral appliance therapy versus CPAP in moderate obstructive sleep apnea
Source: International Congress 2017 – CPAP therapy
Year: 2017
Effect of heated humidification and topical steroids on compliance, nasal symptoms and quality of life in patients with obstructive sleep apnoea syndrome using nasal continuous positive airway pressure
Source: Eur Respir J 2006; 28: Suppl. 50, 412s
Year: 2006
Nasal inflammation and compliance with nasal CPAP therapy in obstructive sleep apnoea (OSA)
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
Efficacy testing for oral appliance therapy in obstructive sleep apnea
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Year: 2021
Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP
Source: Eur Respir J 2002; 20: Suppl. 38, 294s
Year: 2002
Long-term CPAP compliance in women with obstructive sleep apnoea
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
Role of CPAP treatment in elderly with moderate obstructive sleep apnea
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019
Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009
Control of breathing in obstructive sleep apnoea patients: Role of CPAP therapy
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
Oral devices in the treatment of obstructive sleep apnoea short and long-term treatment
Source: Eur Respir J 2003; 22: Suppl. 45, 95s
Year: 2003
The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018
Clinical implications of residual sleep apnoea after chronic CPAP therapy
Source: Breathe 2011; 7: 289-290
Year: 2011
Effects of long term nCPAP treatment on patients with obstructive sleep apnoea syndrom
Source: Eur Respir J 2007; 30: Suppl. 51, 322s
Year: 2007
Effect of treatment with CPAP in patients with resistant hypertension and obstructive apneas
Source: Eur Respir J 2005; 26: Suppl. 49, 113s
Year: 2005
Efficacy of a FOT-based auto-CPAP device for the treatment of obstructive sleep apnea
Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options
Year: 2018
The effect of nasal tramazoline with dexamethasone in obstructive sleep apnoea patients
Source: Eur Respir J 2013; 42: 1055-1063
Year: 2013
Wrist-actigraphic estimation of sleep time under nCPAP treatment in sleep apnoea patients
Source: Eur Respir J 2004; 23: 891-895
Year: 2004
Nasopharyngoscopic evaluation of oral appliance therapy for obstructive sleep apnoea
Source: Eur Respir J 2010; 35: 836-842
Year: 2010
CPAP treatment for obstructive sleep apnoea syndrome after CPAP training term
Source: Eur Respir J 2002; 20: Suppl. 38, 102s
Year: 2002
Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept